Trial Profile
Effects of the FAAH inhibitor PF-04457845 on fear extinction in healthy volunteers
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 May 2017
At a glance
- Drugs PF 4457845 (Primary)
- Indications Psychiatric disorders
- Focus Therapeutic Use
- 09 May 2017 New trial record